Business Context and Reporting Period
This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of June 2018. The report was signed by Zhang Qisen (Johnson), Chief Financial Officer, on June 15, 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing includes a press release as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific financial data. There are no disclosed values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. The document serves primarily as a cover sheet referencing an attached press release.
Investor Verification Checklist
- Verify the content of the attached Press Release (Exhibit 99.1) for actual financial results or material announcements.
- Confirm the discrepancy between the requested company name "Akso Health Group" and the registrant name "Hexindai Inc." listed in the filing.
- Review the full text of the press release to obtain specific revenue, profit, and operational metrics for June 2018.